MK-6552

DRUG5 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HealthyNarcolepsy

Phase 1

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

TerminatedNCT06179407

Merck Sharp & Dohme LLCNarcolepsy

Start: 2024-01-24End: 2024-10-23Updated: 2026-04-14

A Study of MK-6552 and the Effect of Food in Healthy Participants (MK-6552-006)

TerminatedNCT06567002

Merck Sharp & Dohme LLCHealthy

Start: 2024-09-09End: 2024-11-15Updated: 2024-12-04

A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

CompletedNCT06619665

Merck Sharp & Dohme LLCHealthy, Narcolepsy

Start: 2024-03-19End: 2024-07-16Updated: 2024-10-01

A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)

CompletedNCT06662396

Merck Sharp & Dohme LLCHealthy

Start: 2024-06-13End: 2024-09-27Updated: 2024-10-28

A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

CompletedNCT06665230

Merck Sharp & Dohme LLCHealthy, Narcolepsy

Start: 2023-09-20End: 2023-11-20Updated: 2024-10-30